Anesthesia in Pediatric Radiotherapy: A Systematic Literature Review by the SIOP Europe Working Group on Pediatric

Andrada Turcas1,2, Tom Boterberg3, Peter Frykholm4

  • 1Institute of Advanced Studies in Science and Technology, Babeș-Bolyai University, Cluj-Napoca, Romania.

Pediatric Blood & Cancer
|January 3, 2026
PubMed

Insights

Pediatric cancer patients need immobility for radiotherapy (RT), often requiring sedation or general anesthesia (GA). While evidence supports its safety, standardized protocols and more research are crucial for pediatric radiation therapy anesthesia.

Area of Science:

  • Pediatric Oncology
  • Anesthesiology
  • Radiation Therapy

Background:

  • Radiotherapy (RT) is a cornerstone of pediatric cancer treatment, necessitating patient immobility.
  • Sedation and general anesthesia (GA) are commonly used for immobility in pediatric RT, particularly in younger or non-compliant children.
  • Concerns exist regarding acute complications and potential long-term neurodevelopmental effects associated with anesthesia in this population.

Purpose of the Study:

  • To systematically review the literature on sedation and general anesthesia (GA) practices in pediatric radiation therapy (RT).
  • To identify current anesthetic techniques, safety profiles, and complication rates.
  • To inform the development of standardized practice recommendations for pediatric RT anesthesia.

Main Methods:

  • A systematic literature review was conducted following PRISMA guidelines, searching Medline and Embase databases (March-September 2024).
  • Thirty-nine studies focusing on sedation and GA in pediatric RT were included.
  • Data on anesthetic techniques, staffing, monitoring, and complications were extracted and analyzed, noting study quality and heterogeneity.

Main Results:

  • Propofol-based sedation was the most frequently reported technique, demonstrating favorable safety when administered by experienced pediatric anesthetists.
  • Significant heterogeneity was observed in anesthetic techniques, staffing, and monitoring across studies.
  • Complication rates were highly variable and often poorly defined, with additional concerns regarding long-term neurocognitive impact and procedural burden.

Conclusions:

  • Current evidence suggests that sedation and GA can be used safely in pediatric RT.
  • However, the existing literature is limited, inconsistent, and predominantly consists of low-to-moderate quality retrospective studies.
  • There is an urgent need for standardized protocols and prospective research to better define safety, long-term outcomes, and optimal staffing for pediatric RT anesthesia.

Related Concept Videos

Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
937
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
225
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
377
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
191
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
234
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
171